Publications scientifiques

2508 PUBLICATIONS

ANNÉE

JOURNAL

PREMIER AUTEUR

TITRE

ANNÉE2026

JOURNALClinical breast cancer

PREMIER AUTEURBischoff H

TITRECDK4/6 Inhibitors in HER2-positive Metastatic Breast Cancer.

ANNÉE2026

JOURNALEuropean journal of cancer (Oxford, England : 1990)

PREMIER AUTEURValderrama NF

TITREChemo-prAIdict Breast: A deep learning solution for predicting residual disease on biopsies of breast cancer patients treated with neoadjuvant chemotherapy.

ANNÉE2026

JOURNALPhysics and imaging in radiation oncology

PREMIER AUTEURMidani S

TITREFeasibility and workflow efficiency of automated deep inspiration breath-hold for locoregional breast irradiation on a ring-gantry accelerator.

ANNÉE2026

JOURNALEClinicalMedicine

PREMIER AUTEURQuinquenel A

TITREMeasurable residual disease-guided combination of ibrutinib plus venetoclax versus FCR in previously untreated patients with intermediate-risk chronic lymphocytic leukaemia: a phase 2, randomised trial (ERADIC) from the FILO group.

ANNÉE2026

JOURNALOncology letters

PREMIER AUTEURHarlé A

TITRESensitive cell-free DNA assay for accurate detection of RAS and BRAF mutations in liquid biopsies of patients with metastatic colorectal cancer: Final results of the multicentric ColoBEAM study.

ANNÉE2025

JOURNALCardiovascular and interventional radiology

PREMIER AUTEURSteffen DA

TITREDiagnostic Yield of Percutaneous Core Needle Biopsy Immediately After Cryoablation.

ANNÉE2025

JOURNALRevista Brasileira de Pesquisa (Auto)Biográfica

PREMIER AUTEURS. Rossi

TITREMises en recit d’une experience de cancer : formation de soi et circulation des savoirs

ANNÉE2025

JOURNALEuropean journal of breast health

PREMIER AUTEURMoussaron A

TITREAssessing Lead Exposure by Biological Matrices Analysis and Links to Breast Cancer: A Critical Review of Experimental and Epidemiological Findings.

ANNÉE2025

JOURNALBreast cancer research : BCR

PREMIER AUTEURDutheil J

TITREEfficacy of everolimus in patients with hormone receptor positive, HER2 negative, metastatic breast cancer pretreated with CDK4/6 inhibitors.

ANNÉE2025

JOURNALMetabolites

PREMIER AUTEURTodeschi J

TITREMetabolic Heterogeneity in High-Grade Glioma Assessed by Multi-Tracer PET and Ex Vivo Metabolomics: A Systematic Review and Meta-Analysis.

Retrouvez aussi

Unités de recherche, établissements

Projets de recherche

Publications scientifiques